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Abstract
Background: Discerning the genetic contributions to complex human diseases is a challenging mandate that
demands new types of data and calls for new avenues for advancing the state-of-the-art in computational approaches
to uncovering disease etiology. Systems approaches to studying observable phenotypic relationships among diseases
are emerging as an active area of research for both novel disease gene discovery and drug repositioning. Currently,
systematic study of disease relationships on a phenome-wide scale is limited due to the lack of large-scale machine
understandable disease phenotype relationship knowledge bases. Our study innovates a semi-supervised iterative
pattern learning approach that is used to build an precise, large-scale disease-disease risk relationship (D1→D2)
knowledge base (dRiskKB) from a vast corpus of free-text published biomedical literature.
Results: 21,354,075 MEDLINE records comprised the text corpus under study. First, we used one typical disease
risk-specific syntactic pattern (i.e. “D1 due to D2”) as a seed to automatically discover other patterns specifying similar
semantic relationships among diseases. We then extracted D1→D2 risk pairs fromMEDLINE using the learned patterns.
We manually evaluated the precisions of the learned patterns and extracted pairs. Finally, we analyzed the correlations
between disease-disease risk pairs and their associated genes and drugs. The newly created dRiskKB consists of a total
of 34,448 unique D1→D2 pairs, representing the risk-specific semantic relationships among 12,981 diseases with each
disease linked to its associated genes and drugs. The identified patterns are highly precise (average precision of 0.99)
in specifying the risk-specific relationships among diseases. The precisions of extracted pairs are 0.919 for those that
are exactly matched and 0.988 for those that are partially matched. By comparing the iterative pattern approach
starting from different seeds, we demonstrated that our algorithm is robust in terms of seed choice. We show that
diseases and their risk diseases as well as diseases with similar risk profiles tend to share both genes and drugs.
Conclusions: This unique dRiskKB, when combined with existing phenotypic, genetic, and genomic datasets, can
have profound implications in our deeper understanding of disease etiology and in drug repositioning.
Introduction
Phenomics, the systematic study of disease phenotypic
relationships, is the natural complement to genomics in
the post-genomic era [1-3]. Given the rapidly decreasing
cost of genomics research, it has become clear that the
bottleneck in understanding human disease has shifted
dramatically from genetics to phenomics. Automatic
approaches to obtaining and studying the observable
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disease-disease phenotypic relationships are critically
important for unraveling both genetic and environmental
mechanisms of complex diseases. Our long-term research
goal is to develop encompassing and integrative systems
approaches to both disease gene discovery and drug devel-
opment by fully exploiting disease and drug data rang-
ing from lower level genetic connections to immediate
layer genomic data to higher level phenotypic data. While
a large number of genetic and genomic datasets have
been constructed to facilitate our understandings of the
genetic mechanisms of diseases, large-scale disease phe-
notype datasets remain largely incomplete. Currently we
are building a large-scale disease-phenotype relationship
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knowledge base from multiple heterogeneous and com-
plementary sources including published biomedical lit-
erature, patient electronic health records (EHRs), and
biomedical ontologies. This disease-phenotype relation-
ship knowledge base will include relationships such as
disease-risk (i.e. disease-associated genes, environmental
risk factors, and other predisposing diseases), disease co-
morbidity, disease-organ, and disease-manifestation rela-
tionships, among others. As part of our ongoing effort,
this study focuses on building a large-scale disease-disease
risk relationship knowledge base (dRiskKB) by extracting
risk-specific disease pairs (i.e. obesity→type 2 diabetes,
hypertension→stroke) from over 21 million MEDLINE
records.
We recently developed a knowledge-driven pattern-
learning approach to automatically extract disease-
manifestation (symptom) pairs from biomedical literature
[4]. In that study, we leveraged the large amount of
external knowledge from biomedical ontologies (50,543
disease-manifestation pairs defined in the Unified Medi-
cal Language System (UMLS) semantic network in order
to discover disease-manifestation-specific syntactic pat-
terns. Using the learned patterns, we extracted a total of
121,359 disease-manifestation pairs from MEDLINE, the
majority of which had not been captured in ontologies.
Unlike our previous work, which leveraged a large num-
ber of known disease-manifestation pairs from biomedi-
cal ontologies as prior knowledge, this current study did
not benefit from prior knowledge, because no knowledge
base of disease-disease risk pairs currently exists. To cir-
cumvent the problem, we developed a semi-supervised
iterative pattern learning approach to automatically dis-
cover disease-risk-specific syntactic patterns. This semi-
supervised approach requires no external knowledge and
takes a single pattern as the seed. To the best of our
knowledge, this is the first large-scale effort to build a
disease-disease risk relationship knowledge base from the
vast amount of published biomedical literature. The main
contributions of our study are two-fold: First, we develop
an efficient and effective semi-supervised approach to
automatically find textual patterns that specify risk-
specific semantic relationships between diseases. Second,
we build the dRiskKB, a large-scale knowledge base of
disease-disease risk relationships. This unique disease-
phenotype relationship knowledge base, when com-
bined with existing phenotypic, genetic, and proteomic
datasets, can have profound implications in our deeper
understanding of disease etiology and in rapid drug
repositioning.
Background
Perplexing relationships among diseases often go unex-
plained. How, for example, does obesity contribute to
cancer risk? Why are patients with certain neurological
diseases, like Parkinson’s, at lower risk for many cancers?
Understanding the genetic and environmental factors
responsible for these striking risk-specific relationships
among diseases may reveal novel insights into the molec-
ular mechanisms of disease development and lead to
better disease prevention and treatment. It has been
increasingly recognized that phenotypically-related dis-
eases often reflect overlapping molecular causation
[5-9]. Recently, disease phenotypic similarity has become
another major data source exploited by computational
methods in discovering novel candidate disease genes
[10-17]. The advantage of this phenotype-driven approach
over traditional approaches is that we can hypothe-
size that similar phenotypes in two diseases may result
from genes/pathways that are involved in the same bio-
logical processes. For phenotype-driven candidate gene
selection, a two-layered heterogeneous data network is
often constructed where the phenotypic network layer
consists of connections between similar diseases, while
the genetic network layer contains molecular data such
as protein-protein interaction (PPI), pathways, gene co-
expression, or shared protein domain. These two net-
work layers are then linked through known disease-gene
associations [13]. Currently, disease phenotype networks
are mainly constructed based on disease co-morbidity
[18] or text mining of the Online Mendelian Inher-
itance in Man (OMIM) database [10-19]. For sys-
tems approaches to studying phenotypic relationships
among diseases, disease-disease phenotypic associa-
tions (i.e. disease-manifestation, disease-risk, disease-
organ, disease-comorbidity) frommultiple heterogeneous
sources (i.e. published literature, patient EHRs, and
biomedical ontologies) are necessary to mitigate the
incompleteness and biases inherent to many biomedi-
cal networks [20]. In this study, we focus on building a
disease-risk relationship knowledge base by automatically
extracting disease-disease risk pairs fromMEDLINE.
Currently, more than 21 million biomedical records are
available on MEDLINE, making it an excellent source of
disease-risk knowledge. For example, searching PubMed
for the phrase “is a risk factor for” returns a total of 52,460
sentences, among which more than 6,000 sentences are
related to cardiovascular disease risks, and another 6,000
are related to diabetes risks. By the same token, the
single sentence “Obesity is a risk factor for colorectal
cancer, and hyperinsulinemia, a common condition in
obese patients, may underlie this relationship” (PMID
18172327) contains the observed risk relationship among
three diseases: obesity, colorectal cancer and hyperinsu-
linemia. Despite the rich disease risk-specific semantic
relationship knowledge contained in this corpus of pub-
lished biomedical literature, the fact that the knowledge is
buried in free text with limited machine understandability
poses a significant barrier.
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Automatic extraction of biomedical relationships from
MEDLINE is a highly active area of research. Com-
mon approaches for biomedical relation extraction use
rule-based, co-occurrence-based statistical approaches or
natural language processing (NLP) approaches. These
have most often been applied to extract relationships
between drugs, diseases, proteins, and genes [21-24].
Research efforts in disease-risk relationship extraction
tasks, however, have been quite limited. Recently, Liu et
al. manually identified environmental etiological factors
associated with 3,159 diseases by searching the MeSH
annotations of MEDLINE articles [25]. Fiszman et al.
extracted risk factors for Metabolic Syndrome from med-
ical literature by using the MeSH heading “Risk Factors”
to retrieve risk-specific sentences [26]. While Liu’s study
is based on manual curation, Fiszman’s study falls more
under the supervised machine learning approach cate-
gory since it relies on the semantic relationships available
in the Unified Medical Language System (UMLS) seman-
tic network and only focuses on one type of disease:
Metabolic Syndrome. In addition, studies have shown
that using manually assigned MeSH terms, as in both
the above-mentioned studies, results in limited recall in
categorizing biomedical articles [27]. Currently, no risk-
specific disease-disease semantic relationship knowledge
base exists that can be leveraged upon in developing com-
putational approaches to both disease gene discovery and
drug development.
Approach
Automatically extracting disease-risk relationships from
free text is a challenging task. Risk factors for diseases
are often complicated and highly heterogeneous, includ-
ing genes (e.g. APOE, BRCA1), predisposing diseases (e.g.
hypertension, hypogonadism, obesity), chemicals (e.g.
exposure to benzene, estrogen, aflatoxins), life styles and
behavior (e.g. smoking, alcohol use, physical inactivity,
excess salt intake), family history, ethnicity, age, and gen-
der, among many other factors. No specific lexicon of
disease-associated risk factors exists, yet such an entity is
required by most information extraction systems for rela-
tionship extraction. Even our current task of extracting
risk-specific relationships among diseases is difficult. In
general, extracting specific semantic relationships among
the same type of entities, such as disease-co-morbidity,
disease-manifestation, and disease-disease risk pairs, is
more challenging than extracting relationships between
two different types of entities, such as drug-disease, drug-
gene and drug-side effects.
Recent studies in semi-supervised pattern learning
approaches are motivated by the use of a very large collec-
tion of texts (web) [28]. Since semi-supervised approaches
have the advantage of requiring minimal human anno-
tation of data, they are able to extract broad types of
relationships from free text. Semi-supervised learning
approaches have been used in non-biomedical domains
to extract information from the web [29-35]. How-
ever, the potential use of semi-supervised approaches to
build large-scale biomedical databases that enable systems
approaches to disease gene discovery and drug reposition-
ing has not been fully explored.
Recently, we developed a series of semi-supervised pat-
tern learning approaches for named entity recognition
[36,37], relationship extraction [38], and medical image
retrieval from the web [39]. Semi-supervised learning
approaches depend on the regularity of language and
the redundancy of data. A big corpus such as MED-
LINE is ideal for such tasks. In our current study,
we develop an efficient and effective semi-supervised
pattern-learning algorithm to extract disease-disease risk
relationships fromMEDLINE. Since our ultimate research
goal is to develop systems approaches that exploit disease-
phenotype relationships for subsequent network-based
candidate gene prediction and drug repositioning, the
precision and scalability of the relationship extraction
algorithms is critical. Pattern-based relationship extrac-
tion approaches have the advantage of being highly precise
and efficient. In addition, since our approach is semi-
supervised, it has the advantage of requiring minimal
human intervention and no external domain knowledge.
Methods
Build a local MEDLINE search engine
We downloaded a total of 21,354,075 MEDLINE citations
(119,085,682 sentences) published between 1965 and
2012 from the U.S. National Library of Medicine (http://
mbr.nlm.nih.gov/Download/index.shtml). Each sentence
was syntactically parsed with Stanford Parser [40] using
the Amazon Cloud computing service (a total of 3,500
instance-hours with High-CPU Extra Large Instance
used). We used the publicly available information retrieval
library Lucene (http://lucene.apache.org) to create a local
MEDLINE search engine with indices created on both
sentences and their corresponding parse trees.
Build a clean disease lexicon
A highly accurate and comprehensive disease lexicon is
critical for the task of building a high quality disease-
phenotype relationship knowledge base, including our
current task of building dRiskKB.We recently built a large
clean disease lexicon by combining and manually cleaning
all disease terms from UMLS with the following semantic
types: “Disease Disease or Syndrome”, “Sign or Symptom”,
“Neoplastic Process”, “Congenital Abnormality”, “Men-
tal or Behavioral Dysfunction” and “Anatomical Abnor-
mality”, and from the Human Disease Ontology (http://
bioportal.bioontology.org/ontologies/1009). We used this
clean disease lexicon in our recent study of extracting
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disease-manifestation [4] and drug-disease pairs [24] from
MEDLINE. The clean disease lexicon consists of a total
of 70,247 disease terms (corresponding to 28,540 distinct
disease concepts) that appear in MEDLINE. The cleaned
disease lexicon was manually curated by curators from
ThinTek.com and can be obtained for free academic use
by contacting co-author qwang@thintek.com.
Semi-supervised disease-disease risk relationship
extraction
The semi-supervised relationship extraction algorithm is
depicted in Figure 1 and can be formulated as follows:
Given: (1) a seed pattern such as “D1 due to D2” where
both D1 and D2 are disease terms from the input dis-
ease lexicon; (2) a text corpus of MEDLINE sentences and
their corresponding parse trees; (3) a disease lexicon. Do:
starting from the seed pattern, which represents a typical
expression of a disease-disease risk relationship, itera-
tively discover new patterns and extract new pairs with
newly discovered patterns. When no significant number
of new patterns is discovered, rank extracted patterns and
pairs.
Pair Extraction
Seed pattern or patterns extracted from previous itera-
tions were used as search queries to the local MEDLINE
search engine. Both sentences and parse trees that
contained these patterns were retrieved. We extracted
disease-disease pairs from the retrieved sentences if the
disease pairs and the pattern followed the restriction: “D1
pattern D2,” wherein both D1 and D2 are disease terms
as well as noun phrases in the retrieved sentences. The
requirement that both diseases be noun phrases in the
sentences was formulated to avoid false positives. For
example, without this restriction, the incorrect (or incom-
plete) D1→D2 pair “infection→hypertension” would be
extracted from the following sentence: “Herpes simplex
virus type 2 infection is a risk factor for hyperten-
sion” (PMID 15492472), since the disease term “infec-
tion” instead of the more specific term “Herpes simplex
virus type 2 infection” is included in the input disease
lexicon. The correct D1→D2 risk pair in above sentence is
“Herpes simplex virus type 2 infection→hypertension”, not
“infection→hypertension.”
Pattern extraction
Disease pairs (D1-D2) extracted from the previous itera-
tion were used as search queries to the local MEDLINE
search engine. Corresponding sentences and parse trees
were retrieved. Syntactic patterns between the disease
pairs were extracted if D1-D2 pairs and their patterns
conformed to the following format: “D1 pattern D2,”
wherein both diseases D1 and D2 were noun phrases in
the retrieved sentences.
Pattern ranking
The iterative pair extraction and pattern extraction pro-
cesses ran until no significant number of new patterns
was discovered (two iterations in this study). We then
ranked extracted patterns. Each pattern was ranked based
on how similar its output (its associated D1-D2 pairs) was
to the output of the seed pattern. Using the output of the
seed pattern (p0) as the gold standard, we developed three
pattern-ranking algorithms: (1) Precision-based ranking,
wherein patterns were ranked based on pattern specificity;
(2) Recall-based ranking, wherein patterns were ranked
based on pattern generality; and (3) F1-based pattern
ranking, wherein both pattern specificity and generality
were taken into account. We define ins(p) to be the set of
pairs matched by pattern p, and the intersection ins(p) ∩
ins(p0) as the set of pairs matched by both pattern p and
seed pattern p0. The Precision-based, Recall-based, and
F1-based ranking scores are defined as below:
RSprecision(p) = |ins(p) ∩ ins(p0)||ins(p)| (1)
RSrecall(p) = |ins(p) ∩ ins(p0)||ins(p0)| (2)
RSF1(p) = 2 ∗ precision(p) ∗ recall(p)precision(p) + recall(p) (3)
Figure 1 The semi-supervised pattern-learning approach for extracting disease-disease risk pairs fromMEDLINE.
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Pair ranking
Extracted pairs were ranked based on both the scores of
their associated patterns and their frequency counts in
MEDLINE. A reliable D1→D2 pair is one that is associ-
ated with reliable patterns many times. The ranking score




log(RS(Pi)) ∗ count(Pi,R) (4)
RS(Pi) is the score of its associated patterns (Pi), which is
defined in (1), (2), or (3), and count(Pi,R) is the number
of times that the pair is associated with the pattern in the
entire MEDLINE corpus.
Pattern selection, database construction andmanual
evaluation
From the top-ranked patterns (based on F1-based pat-
tern ranking method), we manually selected a total of 26
disease risk-specific patterns that associated with at least
100 unique disease-disease risk pairs. These patterns had
both high precisions and recalls as determined by how
they ranked and by the manual examination. The manual
examination of top-ranked patterns took about 15 min-
utes. We then extracted disease-disease risk pairs from
MEDLINE associated with these patterns. These pairs
were used in in building dRiskKB database.
Using each of the 26 selected patterns and their asso-
ciated disease-disease risk pairs as search queries to the
local MEDLINE search engine, we retrieved sentences
that contained these patterns and disease pairs in the for-
mat of “D1 pattern D2.” From these retrieved sentences,
we randomly selected 50 sentences for each pattern (a
total of 26*50 = 1300 sentences) for manual curation.
Two annotators independently curated these sentences.
Disease-disease risk pairs from these sentences were clas-
sified to one of three categories: correct, partially correct,
and incorrect. Precisions of patterns as well as of pairs
were calculated using pairs that were identified as correct
by both annotators; these functioned as the gold standard.
The kappa statistics thatmeasures the agreement between
the two annotators [41] was as high as 0.95.
Systematically analyze extracted disease-disease risk
(D1→D2) pairs
Analyze the correlation between disease-risk relationships
and disease-associated genes
We analyzed shared the genetic components underlying
the direct D1→D2 risk pairs. We also analyzed the shared
genes for disease-disease (D1-D2) pairs with overlap-
ping risk diseases (D1←{d11, d12, . . . , d1n}, D2 ← {D21,
d22, . . . , d2m}) or D1-D2 pairs with overlapping effect
diseases (D1→{d11, d12, . . . , d1n}, D2 →{d21, d22, . . . ,
d2m}). We used two complementary sources of disease-
gene association knowledge for this analysis. The first
one was from the OMIM (Online Mendelian Inheri-
tance in Man) (data accessed in 04/2012) [42], and con-
sisted of 14,870 pairs for 2,391 diseases and 8,929 genes.
The second was from the NHGRI’s (National Human
Genome Research Institute) GWAS Catalog database
(data accessed in 01/2012) [43] and consisted of 5,895
disease/trait-gene pairs for 520 diseases and 3,795 genes.
OMIM is a database that catalogues many Mendelian
diseases with known genetic components. The GWAS
Catalog database is an online database of SNP-trait asso-
ciations derived from genome-wide association studies.
Many diseases from the GWAS catalog are common com-
plex diseases such as hypertension and diabetes. We first
mapped disease terms between the extracted D1→D2
pairs and the disease-gene pairs from OMIM and from
the GWAS catalog. We calculated the average number of
shared genes between disease-disease pairs (D1→D2 risk
pairs, D1-D2 pairs with shared predisposing disease, or
D1-D2 pairs with shared effect diseases) and compared
the number to all disease-disease pairs for mapped dis-
eases. For disease-disease pairs that shared risk diseases
or effect diseases at different cutoffs, we calculated the
average number of shared genes at each cutoff.
Analyze the correlation between disease-risk relationships
and disease-associated drugs
Similarly, we analyzed the shared drug treatments for
direct D1→D2 risk pairs, for D1-D2 pairs with shared
predisposing diseases, and for D1-D2 pairs with shared
effect diseases. We extracted a total of 52,000 disease-
drug treatment pairs from ClinicalTrials.gov (http://www.
clinicaltrials.gov/), a registry of federally and privately
supported clinical trials conducted in the United States
and around the world (www.clinicaltrials.gov), as the
disease-drug association knowledge. These disease-drug
pairs consisted of 9,591 diseases and 2,035 drugs. We
mapped the disease terms between. These disease-drug
pairs consisted of 9,591 diseases and 2,035 drugs. We
mapped the disease terms between disease-drug pairs and
disease-disease risk pairs. As in the above genetic corre-
lation study, we calculated the average number of shared
drugs between D1→D1 risk pairs and compared it to that
of all disease-disease pairs. For disease-disease pairs that
shared risk diseases or effect diseases at different cut-offs,
we calculated the average number of shared drugs at each
cutoff.
Results
Top ranked patterns contain many disease risk-specific
patterns
Using the typical disease risk-specific pattern “D1 due
to D2” as a search query to the local MEDLINE search
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engine, we retrieved a total of 22,482 sentences contain-
ing two diseases and the seed pattern in the format of
“D1 due to D2,” wherein both D1 and D2 were diseases
and also noun phrases in the sentences. From these sen-
tences, we extracted a total of 14,183 unique D1←D2
pairs (“Pair Extraction”). We then used these extracted
D1←D2 pairs as search queries to the local MEDLINE
search engine to find their associated patterns (“Pattern
Extraction”). After two iterations, we stopped the process
since not many additional risk-specific patterns with both
high precision and high recall were discovered. We then
ranked the extracted patterns (a total of 2,119,091) using
the output associated with the seed pattern as the gold
standard (the 14,183 D1←D2 pairs associated with the
seed “D1 due to D2”). The three pattern-ranking meth-
ods are Precision-based, Recall-based and F1-based. Top
10 ranked patterns for each method are listed in Table 1
(patterns for D1←D2 relationship) and in Table 2 (pat-
terns for D1→D2). The risk-specific patterns associated
with at least 1000 distinct disease-disease risk pairs are
highlighted.
As shown Table 1, the Precision-based method was able
to rank disease-risk-specific patterns highly on the list. For
example, all of the top 10 patterns as determined by the
method Precision-based are risk-specific patterns, includ-
ing “D1 owing to D2,” “D1 attributable to D2,” and “D1 was
caused by D2.” However, the majority of these top-ranked
patterns were associated with less than 1000 disease pairs;
the exception is the pattern “D1 resulting from D2,” which
was associated with 1,281 pairs. On the other hand, top
patterns ranked by the F1-based method included more
risk-specific patterns with high recalls. For example, the
second highest ranking pattern, “D1 caused by D2,” was
associated with a total of 8,297 distinct D1←D2 pairs.
The third highest ranking pattern, “D1 secondary to D2,”
was associated with 6,499 distinct D1←D2 pairs. The
Recall-basedmethod performed similarly to the F1-based
ranking method in ranking many risk-specific patterns
with high recalls highly.
Using the same 14,183 D1←D2 pairs associated with
the seed pattern “D1 due to D2” as the gold standard, we
also learned typical patterns that specify risk relationship
in the reverse direction (D1→D2), such as “D1 causing
D2,” and “D1 as a cause of D2.” As shown in Table 2,
all top 10 patterns ranked by the Precision-based method
are disease risk-specific patterns such as “D1 is a leading
cause of D2” and “D1 as a cause of D2.” Even though these
top-ranked patterns are highly specific, they had limited
recalls in that each of them was associated with less than
1000 D1→D2 pairs. Both the F1-based and Recall-based
methods were able to rank risk-specific patterns with high
recalls at the top. For example, two additional risk-specific
patterns with high recalls appeared in the top 10 patterns
ranked by the F1-based approach: “D1 causing D2,” (2,260
pairs) and “D1 as a cause of D2” (1,463 pairs).
Disease-disease risk pairs extracted using the selected
patterns are of high precision
We manually examined a total of 1,300 (50 for each of
the 26 selected patterns) randomly selected sentences that
contained patterns and their associated disease-disease
risk pairs in the format “D1 pattern D2.” A pattern is
correct for a given sentence if the semantic relationship
between its associated disease-disease pairs is disease-
risk-specific. As shown in Figure 2, all the selected pat-
terns were highly precise, with an average precision of
0.99.
We then calculated the precisions of disease pairs asso-
ciated with these patterns. The correctness of the pairs
depends on not only their associated patterns but also
the underlying disease lexicon and the parsing accuracy of
Stanford parser. From the 1,300 sentences, we extracted a
Table 1 Top 10 ranked patterns and numbers of associatedD1←D2 pairs
Precision-based Recall-based F1-based
Pattern Pairs Pattern Pairs Pattern Pairs
“D1 due to D2” 14,183 “D1 due to D2” 14,183 “D1 due to D2” 14,183
“D1 was due to D2” 198 “D1 and D2” 205,942 “D1 caused by D2” 8,297
“D1 owing to D2” 175 “D1 in D2” 50,902 “D1 secondary to D2” 6,499
“D1 attributable to D2” 279 “D1 caused by D2” 8,297 “D1 from D2” 7,993
“D1 was caused by D2” 181 “D1 associated with D2” 27,477 “D1 associated with D2” 27,477
“D1 due to chronic D2” 146 “D1 secondary to D2” 6,499 “D1 in patients with D2” 20,221
“D1 due to severe D2” 187 “D1 in patients with D2” 20,221 “D1 in D2” 50,902
“D1 as a result of D2” 516 “D1 with D2” 35,203 “D1 of D2” 11,919
“D1 resulting fromD2” 1,281 “D1 from D2” 7,993 “D1 resulting from D2” 1,281
“D1 attributed to D2” 184 “D1, D2” 99,881 “D1 related to D2” 1,616
Risk-specific patterns associated with≥1000 pairs are highlighted.
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Table 2 Top 10 ranked patterns and numbers of associatedD1→D2 pairs
Precision-based Recall-based F1-based
Pattern Pairs Pattern Pairs Pattern Pairs
“D1 due to D2” 14,183 “D1 due to D2” 14,183 “D1 due to D2” 14,183
“D1 is a leading cause of D2” 132 “D1 and D2” 205,942 “D1 with D2” 35,203
“D1 is the most common cause of D2” 188 “D1 with D2” 35,203 “D1 D2” 12,887
“D1 is a major cause of D2” 281 “D1, D2” 99,881 “D1 causing D2” 2,260
“D1 is the main cause of D2” 104 “D1 D2” 12,887 “D1 patients with D2” 2,578
“D1 is a frequent cause of D2” 104 “D1 or D2” 38,841 “D1 as a cause of D2” 1,463
“D1 is an important cause of D2” 262 “D1 in D2” 50,902 “D1 without D2” 3,703
“D1 is a common cause of D2” 351 “D1 associated with D2” 27,477 “D1 complicated by D2” 3,422
“D1 as cause of D2” 117 “D1, and D2” 28,942 “D1 or D2” 38,841
“D1-induced D2” 558 “D1 causing D2” 2,260 “D1 and D2” 205,942
Risk-specific patterns associated with ≥1000 pairs are highlighted.
total of 1,203 distinct mention-level disease-disease pairs,
among which 1,085 pairs were correct with a precision of
0.919 and 1,185 pairs were partially correct with a pre-
cision of 0.985. The high precision of the extracted pairs
reflects that the specificity of the selected patterns, the
accuracy of the manually curated input disease lexicon,
and the strategy of using parse trees to enforce the rule
that disease terms be noun phrases in the sentences. The
majority of partially incorrect extracted disease pairs was
caused by the way we delineated the noun phrase bound-
ary. For example, from the sentence “Sebaceous carci-
noma arising from Bowen’s disease of the vulva” (PMID
3767405), the partial pair “Sebaceous carcinoma-Bowen’s
disease” was extracted, rather than the more complete
pair ‘Sebaceous carcinoma-Bowen’s disease of the vulva”.
The disease term “bowen’s disease” not “bowen’s disease
of the vulva” is included in the disease lexicon. In addition,
“bowen’s disease” by itself is a noun phrase in the parse
tree of the sentence: (ROOT (NP (NP (JJ sebaceous) (NN
carcinoma)) (VP (VBG arising) (PP (IN from) (NP (NP
(NP (NNbowen) (POS ’s)) (NN disease)) (PP (IN of) (NP
(DT the) (NN vulva)))))).
In our current study, we learned many patterns after
two iterations; however, many of these patterns are similar
such as “due to” and “was due to.” One of the limitations of
our study is that we did not merge similar pattern since we
did not have an automatic way to do this systematically.
However, this limitation should not have affected our eval-
uation results. Themajority of the 26 selected patterns are
distinctive, such as “due to”, “caused by”, and “secondary
to”. In addition, the results across these 26 patterns are
very consistent.
Figure 2 Pattern precisions.
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Pattern extraction and ranking algorithms are robust in
terms of seed patterns
Since the performance of many bootstrapping iterative
pattern-learning systems may depend on the choice of
initial seeds, an important question is whether these dif-
ferent starting points lead to different results. We inves-
tigated this issue by starting from five different seed
patterns and examined whether the 26 selected risk-
specific patterns that were selected from top-ranked pat-
terns of the seed pattern “D1 due to D2” are also enriched
in top ranked patterns when other seeds are used.
The five seed patterns include three typical risk-specific
patterns with both high precisions and recalls:“D1 due
to D2” (seed1), “D1 caused by D2” (seed2), and “D1 sec-
ondary to D2” (seed3), a risk-specific pattern with high
precision but relatively low recall: “D1 attributable to D2”
(seed4), and a non-risk-specific general pattern: “D1 and
D2” (seed5). We ran the iterative pattern extraction and
relationship extraction for two iterations using each of the
five patterns as the seed. After two iterations, we ranked
the extracted pattern using the F1-based pattern ranking
method and counted how many of the 26 risk-specific
patterns appeared among top-ranked pairs at 10 differ-
ent ranking cutoffs (top 10, 20, . . . , 100). As shown in
Table 3, the outputs (as measured by the appearance of
the 26 risk-specific patterns) among three seed patterns
with both high precisions and recalls (seed1, seed2 and
seed3) are similar. For example, 24 of the 26 risk-specific
patterns appeared in the top 100 patterns for seed “D1
caused by D2”. Top-ranked patterns for the relatively more
specific risk-specific pattern (“D1 attributable to D2”) are
also enriched with patterns from the 26 selected patterns,
however, the enrichment is smaller compared to those for
seed1, seed2 and seed3. As a negative control, we also
Table 3 Number of disease-risk-specificpatterns among
top-ranked patterns for five different seeds: seed1 (“D1
due to D2”), seed2 (“D1 caused by D2”), seed3 (“ D1
secondary to D2”), seed4 (“ D1 attributable to D2”), and
seed5 (“D1 andD2)”
Rank Seed1 Seed2 Seed3 Seed4 Seed5
10 4 4 4 5 1
20 6 7 7 11 3
30 8 11 11 11 3
40 12 15 15 12 4
50 16 20 15 15 4
60 21 21 17 15 4
70 23 22 21 16 4
80 25 23 22 16 5
90 26 24 23 16 5
100 26 24 23 16 5
used a non-risk-specific pattern “D1 and D2” as seed.
The enrichment of disease-specific patterns among top
ranked patterns for this non-risk-specific seed is much
smaller compared to those of other four seeds. In sum-
mary, the pattern-ranking algorithm is robust in terms of
seed choices as long as the seed is a risk-specific pattern
with relatively high precision and recall (aka, a typical pat-
tern specifying the risk relationship among diseases) is
used. We experimented in using more than one patterns
as seeds, and found that the algorithm is not sensitive to
the number of seed patterns used (data not shown).
Disease-disease risk pairs tend to share both genes and
drugs
The F1-based ranking method prioritized many risk-
specific patterns with both high precisions and high
recalls on the top; however not all top-ranked patterns
were necessarily disease-risk-specific patterns. We man-
ually selected 26 risk-specific patterns with high recalls
from the top-ranked patterns and then extracted disease-
disease risk pairs from MEDLINE using these selected
patterns. Examples of these selected patterns are “D1
due to D2,” “D1 caused by D2,” “D1 secondary to D2,”
and “D1 resulting from D2.” Using these patterns, we
extracted a total of 34,448 unique disease-disease risk
pairs (D1←D2), representing 12,981 diseases. We then
analyzed the relationships between these 34,448 disease-
disease risk pairs and disease-related genes and drugs
(Table 4).
As shown in Table 4, among extracted D1→D2 pairs
with mapped disease names between D1→D2 pairs and
disease-gene pairs, 3.79% pairs shared genes as deter-
mined by disease-gene pairs from OMIM. The average
number of shared genes was 5.36, a significantly higher
number than the average of 0.016 for D1-D2 combi-
nation pairs (178,503 pairs for the same 598 mapped
diseases). We observed a similar trend when the disease-
gene associations from the GWAS studies were used.
Among D1→D2 pairs with mapped diseases, 13.64%
shared genes, a much higher percentage than the 3.79%
resulting when the disease-gene association data from
Table 4 Percentagesof disease-diseaserisk pairs (D1→D2)
that share any genes or drugs (Column 2), the average
numbers of shared genes or drugs for D1→D2 pairs
(Column 3), and the average numbers of shared genes or
drugs fordisease-diseasecombinations(D1-D2) (Column4)
Source Percent Average Average
(D1→D2) (D1→D2) (D1-D2
combinations)
Disease-gene (OMIM) 3.79% 5.36 0.016
Disease-gene (GWAS) 13.64% 1.91 0.134
Disease-drug 42.12% 4.36 0.222
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OMIM was used. The average number of shared genes
was 1.91, a significantly higher number than the number
of 0.134 for D1-D2 combinations.
We also investigated whether D1→D2 risk pairs were
treated by the same drugs. As shown in Table 3, as many
as 42.13% of D1→D2 pairs shared drug treatments. The
percentage was significantly higher than the percentages
of D1→D2 pairs that shared genetic components, indicat-
ing that two different diseases with risk-specific seman-
tic relationships were treated with the same drugs even
though they did not share any common underlying genetic
mechanism. The average number of shared drugs between
disease risk pairs was 4.36, significantly higher than the
number for all disease-disease combinations: 0.222.
In summary, disease-disease risk pairs tend to share
common genetic components and to be treated by the
same drugs. Among all 34,448 observed disease-disease
risk pairs, only a very small percentage of pairs shared any
genes, indicating that we can leverage on the observed
strong disease-disease risk-specific relationships to dis-
cover underlying novel genetic mechanisms. Similarly, a
large percentage (about 58%) of D1→D2 risk pairs don’t
share any drug treatments yet, indicating the usefulness
of the extracted D1→D1 risk pairs in both drug target
discovery and drug repositioning.
Disease-disease pairs with similar risk or effect disease
profiles tend to share both genes and drugs
In the previous section, we showed that a disease and its
predisposing diseases (direct D1←D2 risk relationship)
tended to share both genes and drug treatments. In this
section, we investigated whether two diseases with shared
risk diseases or effect diseases also shared any genes or
drug treatments. As shown in Figure 3, a strong positive
correlation between shared risk diseases or effect diseases
Figure 3 Correlations between disease-disease pairs with shared
risk or effect diseases and their associated genes (OMIM).
and shared genes was evidenced. For example, the aver-
age number of shared genes for all D1-D2 combination
pairs was 0.017 (≥0). The number significantly increased
to 0.664 for pairs that shared at least six risk diseases
and to 0.428 for pairs that shared at least six effect dis-
eases (≥6). In addition, the correlation was stronger for
disease-disease pairs with shared risk diseases than pairs
with shared effect diseases.
We observed a similar positive correlation between
disease-disease pairs with shared risk diseases or effect
diseases and shared genes when the disease-gene asso-
ciations from the GWAS studies were used (Figure 4).
The average number of shared genes for all D1-D2 com-
bination pairs was 0.143 (≥0). The number significantly
increased to 1.511 for pairs that shared at least six risk dis-
eases (≥6) and to 0.459 for pairs that shared at least one
effect disease (≥1). However, not many D1-D1 pairs (with
disease names mapped to disease-gene pairs in GWAS)
shared more than one effect disease.
A strong positive correlation between D1-D2 pairs with
shared cause or effect diseases and shared drugs was evi-
denced (Figure 5). The average number of shared drugs
for all D1-D2 pairs was 0.273. The number significantly
increased to 8.923 for pairs that shared at least nine risk
diseases (≥9)and to 4.145 for pairs that shared at least
nine effect diseases (≥9). Similar to the correlations when
disease-gene associations fromOMIMwere used, the cor-
relation was stronger for D1-D2 pairs with shared risk
diseases than for pairs with shared effect diseases.
Risk graphs for obesity and type 2 diabetes
In order to visualize the disease risk relationship knowl-
edge represented in dRiskKB, we plotted one weighted
risk graph for obesity (Figure 6) and one for Type 2 Dia-
betes (T2D) (Figure 7). The edge weight was determined
Figure 4 Correlations between disease-disease pairs with shared
risk or effect diseases and their associated genes (GWAS).
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Figure 5 Correlations between disease-disease pairs with shared
risk or effect diseases and their associated drugs.
by the ranking scores of pairs (“Pair Ranking”). A total
of 55 diseases caused or were caused by obesity. The top
predisposing disease identified for obesity (D1→obesity)
was hyperphagia, a serious eating disorder defined as an
extreme, insatisfied drive to consume food. The second-
most predisposing disorder for obesity was identified as
overeating. On the other hand, the top five diseases caused
by obesity (obesity→D2)were determined to be fatty liver,
metabolic disorders, coronary heart disease, hypertension,
and respiratory failure.
A total of 35 diseases were directly linked to T2D in
the dRiskKB (Figure 7). The top one predisposing disease
for T2D (D1→T2D) was identified as obesity. Another
predisposing disease for T2D was determined to be
chronic pancreatitis. The top five diseases caused by T2D
(T2D→D2) were nephropathy, hypoglycemia, cardiovas-
cular disease, cognitive deficits, and Charcot-Marie-Tooth
disease.
Figure 6Weighted risk graph directly related to obesity.
Figure 7Weighted risk graph directly related to type 2 diabetes
(T2D).
Some diseases have more complicated risk graphs than
that of obesity or T2D. For example, hypertension is a
condition with a total of 809 directly linked diseases that
either cause or are caused by hypertension (graphs not
shown).
Discussion
We built dRiskKB, a disease-disease risk relation-
ship knowledge base by developing an iterative, semi-
supervised learning approach to extract a large number of
disease-disease risk pairs from the over 21 million pub-
lished MEDLINE records currently available. Diseases in
dRiskKB were linked to their known genes, SNPs, and
drug treatments. We also systematically analyzed the rela-
tionships between disease-disease risk pairs and disease-
associated genes as well as drug treatments. To the best of
our knowledge, dRiskKB is the first large-scale disease risk
relationship knowledge base built from the large corpus of
published biomedical literature.
Nevertheless, our study has several limitations and can
be greatly improved in future studies. First, the 26 pat-
terns were selected from top-ranked patterns by manually
removing non-disease-risk-specific patterns such as “D1
and D2” and “D1 or D2.” The limitation is that even
though it is obvious that these patterns are non-disease-
risk-specific, it is difficult to test it formally. Second, even
though dRiskKB is precise and consists of a total of 34,448
disease-disease risk pairs, one of the major limitations
is that we could not assess its coverage due the lack of
a gold standard. Third, currently, dRiskKB only contains
the risk relationships among diseases. Many factors other
than disease can contribute to the risk of a disease, includ-
ing genes (e.g. APOE, BRCA1), chemicals (e.g. exposure
to benzene, estrogen, aflatoxins), life styles and behav-
ior (e.g. smoking, alcohol use, physical inactivity, excess
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salt intake), family history, ethnicity, age, gender, and
even microbiome in the human body. Automatic extrac-
tion of the risk-specific relationship between diseases and
these risk factors is a highly challenging task since no
specific lexicon of these risk factors currently exists, yet
such an entity is required by most information extrac-
tion systems for relationship extraction. Fourth, the risk
relationships among diseases are often context-sensitive.
For example, in the sentence “Depression is a risk fac-
tor for coronary artery disease in men,” the disease-
disease-population triple “depression CAUSE coronary
artery disease IN men,” rather than the disease-disease
pair “depression-coronary artery disease,” better captures
the context (patient)-specific risk relationships among
diseases. Another example is “hypertriglyceridaemia is a
risk factor for coronary artery disease in diabetic pop-
ulations,” where triple ‘hypertriglyceridaemia-coronary
artery disease-diabetic populations’ better captured the
risk relationship between the two diseases. In one of
our previous studies, we developed a combined machine
learning and NLP approach to accurately extract clini-
cal trial participant information, including demographics,
trial size, disease, or symptoms and their descriptors from
RCT abstracts [44]. In our future study, we will improve
dRiskDB by automatically extracting patient characteris-
tics from sentences.
The majority of extracted D1→D2 risk pairs (96.21%
based on OMIM and 86.36% based on GWAS) don’t share
any known genes. At least three factors may account for
this. First of all, not all disease-associated genes have
been discovered so far. The disease-gene associations
from OMIM or GWAS may only cover a small percentage
of all disease-associated genes. Second, we only com-
pared the direct gene overlap. It is possible that common
genetic pathway or function modules (not necessarily the
same genes) are responsible for the observed D1→D2 risk
semantic relationships. Third, non-genetic factors such as
environmental factors, diet or socioeconomic status may
be responsible for the observed risk relationships among
diseases. The facts that D1→D2 risk pairs shared signifi-
cantly more genes than all disease combinations and that
only a small percentage of the large number of observed
D1→D2 pairs shared any genes provided both motiva-
tion and opportunity for developing phenotype-driven
network-based approaches to leverage on the observed
strong risk-specific semantic relationships among diseases
in discovering novel disease candidate genes.
Conclusions
In this study, we present a semi-supervised approach in
order to build a large-scale and precise disease-disease
risk relationship knowledge base (dRiskKB). The newly
created dRiskKB consisted of a total of 34,448 unique
D1→D2 risk pairs representing 12,981 diseases with each
linked to its associated genes and drugs. We have shown
that diseases and their risk diseases as well as diseases
with similar risk profiles tend to share both genes and
drugs. This unique dRiskKB, when combined with exist-
ing phenotypic, genetic, and proteomic datasets, can have
profound implications in our deeper understanding of
disease etiology and in rapid drug repositioning.
Data availability
The extracted disease-disease risk pairs as well as
their associated genes and drugs, the 26 patterns that
were used in constructing dRiskKB, and the dataset
of curated sentences for pattern precision evaluation
are available at: http://nlp.case.edu/public/data/dRiskKB.
The curated disease lexicon was created by ThinTek
and can be obtained by contacting QuanQiu Wang
at qwang@ThinTek.com. We plan to update dRiskKB
semi-annually.
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